Precision Medicine to Shape Future Healthcare: Dr Jitendra Singh
Union Minister says India is building indigenous solutions through genomics, AI, gene therapy and biotechnology
- Dr. Jitendra Singh said precision medicine will transform future healthcare.
- He highlighted Genome India Mission as the foundation for personalised treatment.
- India is developing indigenous solutions in gene therapy, AI and nuclear medicine.
- Minister called preventive healthcare key to achieving Viksit Bharat by 2047.
GG News Bureau
New Delhi, 27th June: On the eve of National Doctors’ Day, Union Minister of State (Independent Charge) for Science and Technology Dr. Jitendra Singh said precision medicine, powered by genomics, artificial intelligence and emerging technologies, will redefine the future of healthcare, positioning India as a global hub for affordable and patient-centric medical innovation.
Addressing a special Doctors’ Day conclave, Dr. Singh said India’s vast genetic diversity and expanding scientific ecosystem provide a unique opportunity to develop indigenous healthcare solutions for both domestic and global challenges. He said the country is steadily advancing in gene therapy, nuclear medicine and biotechnology to deliver personalised treatment based on an individual’s genetic profile, lifestyle and environment.
Highlighting the progress of the Genome India Mission, the Minister said the sequencing of over 10,000 genomes has laid the foundation for precision medicine and will accelerate research into rare diseases, genetic disorders and targeted therapies.
He said recent breakthroughs, including indigenous gene therapy for haemophilia and advances in nuclear medicine, demonstrate India’s growing capability to develop globally relevant healthcare solutions through homegrown innovation.
Dr. Singh also underlined the expanding role of artificial intelligence across healthcare, stating that AI is transforming disease diagnosis, biomedical research, medical education and telemedicine while improving clinical decision-making and expanding access to specialist care in remote areas.
The Minister said India is witnessing a shift from manufacturing medicines discovered abroad to developing new drugs through indigenous research and innovation. He cited the development of India’s first homegrown antibiotics for drug-resistant infections as a milestone in pharmaceutical research.
Emphasising preventive healthcare, Dr. Singh said early screening and timely intervention are essential to tackle the rising burden of non-communicable diseases such as diabetes, cancer and fatty liver disease, particularly among younger people.
He expressed confidence that continued investments in science, research and collaboration among government, academia and industry would establish India as a global leader in next-generation healthcare while advancing the vision of Viksit Bharat 2047.
